| |
|
|
|
|
|
|
|
|
| |
|
| |
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
LIFE
SCIENCES LIMITED |
|
|
| |
Serene Chambers, Road No.7, Banjara Hills, Hyderabad- 500 034 |
|
|
| |
UNAUDITED
FINANCIAL RESULTS FOR |
|
|
| |
THE THREE
MONTHS ENDED 31 st Mar, 2004. |
(Rs. in lakhs) |
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
THREE |
Corresponding |
YEAR TO |
PREVIOUS
|
|
|
| |
Sl. |
PARTICULARS |
MONTHS |
Three months |
DATE FIGURES |
ACCOUNTING |
|
|
| |
No. |
|
ENDED |
ended 31.03.03 |
FOR CURRENT |
YEAR |
|
|
| |
|
|
31.03.2004 |
in the previous |
YEAR ENDED |
ENDED |
|
|
| |
|
|
|
Year |
31.03.2004 |
31.03.2003 |
|
|
| |
1 |
Net Sales/Income from operations: |
|
|
|
|
|
|
| |
|
Export Sales |
557.55 |
1449.53 |
3513.90 |
3103.15 |
|
|
| |
|
Domestic Sales |
458.23 |
240.31 |
1527.68 |
1417.24 |
|
|
| |
|
Contract technical services |
55.53 |
0.00 |
76.24 |
0.00 |
|
|
| |
2 |
Other Income |
24.73 |
32.40 |
54.16 |
178.70 |
|
|
| |
|
Total Income |
1096.04 |
1722.24 |
5171.98
|
4699.09 |
|
|
| |
3 |
Total Expenditure |
|
|
|
|
|
|
| |
|
a) Decrease (Increase)in stock in
trade |
(45.21) |
15.79 |
(110.32) |
(369.74) |
|
|
| |
|
b) Consumption of raw materials |
370.70 |
845.92 |
1889.49 |
2262.20 |
|
|
| |
|
c) Personnel cost |
57.49 |
52.84 |
212.83 |
165.69 |
|
|
| |
|
d) Other expenditure - Duties |
46.78 |
17.54 |
186.58 |
179.39 |
|
|
| |
|
-
Manufacturing Exps |
173.76 |
252.05 |
699.71 |
626.15 |
|
|
| |
|
- R & D
Exps |
125.96 |
52.76 |
510.89 |
330.93 |
|
|
| |
|
- Selling
Exps |
27.97 |
37.49 |
95.25 |
103.56 |
|
|
| |
|
-
Administrative Exps |
157.26 |
89.85 |
414.52 |
268.64 |
|
|
| |
4 |
Interest |
15.79 |
5.36 |
47.00 |
16.16 |
|
|
| |
5 |
Depreciation |
50.29 |
46.75 |
194.39 |
148.68 |
|
|
| |
6 |
Profit (+)/Loss(-) before taxation (1+2-3-4-5) |
115.25
|
305.89 |
1031.64
|
967.43 |
|
|
| |
7 |
Provision for Taxation : Current Tax |
(8.42) |
30.36 |
60.00 |
77.00 |
|
|
| |
|
Deffered Tax |
83.85 |
181.09 |
252.33 |
327.42 |
|
|
| |
8 |
Net Profit (+)/Loss(-) (6-7) |
39.82
|
94.44 |
719.31 |
563.01 |
|
|
| |
9 |
Paid-up equity share capital |
500.00 |
440.00 |
500.00 |
440.00 |
|
|
| |
10 |
Reserves excluding revaluation
Reserve |
---- |
---- |
|
4758.01 |
|
|
| |
11 |
Basic and diluted E P S for the period for the year |
0.18 |
2.15 |
3.18 |
12.80 |
|
|
| |
|
to date and for the previous year
(not annualised) |
(Face value Rs.2) |
(Face value Rs.10) |
(Face value Rs.2) |
(Face value Rs.10) |
|
|
| |
12 |
Aggregate of Non-promoter share |
|
|
|
|
|
|
| |
|
holding :- Number of Shares |
|
|
11665400 |
1807028 |
|
|
| |
|
Percentage of Share holding |
|
|
46.66% |
41.07% |
|
|
| |
SEGMENT WISE REVENUE,RESULTS AND CAPITAL EMPLOYED |
|
|
|
| |
1 |
SEGMENT REVENUE :- |
|
|
|
|
|
|
| |
a) |
Bulk Drugs |
345.93 |
225.26 |
967.43 |
979.30 |
|
|
| |
b) |
Intermediates under
Contract Services |
556.10 |
1260.80 |
3199.87 |
2697.02 |
|
|
| |
c) |
Other Products |
167.89 |
203.77 |
946.96 |
844.07 |
|
|
| |
d) |
Research &
Development |
1.38 |
0.00 |
3.56 |
0.00 |
|
|
| |
|
Net Sales from Operations |
1071.30
|
1689.83
|
5117.82 |
4520.39 |
|
|
| |
2 |
SEGMENT RESULTS :- |
|
|
|
|
|
|
| |
|
Profit/(Loss) before tax and interest: |
|
|
|
|
|
|
| |
a) |
Bulk Drugs |
91.87 |
22.99 |
266.11 |
194.49 |
|
|
| |
b) |
Intermediates under
Contract Services |
296.11 |
455.97 |
1693.82 |
1201.72 |
|
|
| |
c) |
Other Products |
54.75 |
83.26 |
347.38 |
334.90 |
|
|
| |
d) |
Research &
Development |
(124.57) |
0.00 |
(507.33) |
(330.93) |
|
|
| |
|
TOTAL |
318.16 |
562.22
|
1799.98 |
1400.18 |
|
|
| |
Less: |
I) Interest |
15.79 |
5.36 |
47.00 |
16.16 |
|
|
| |
|
ii) Other Un-
allocable exps net off |
|
|
|
|
|
|
| |
|
un- allocable
Income |
187.12 |
250.97 |
721.34 |
416.59 |
|
|
| |
|
Total Profit Before Tax |
115.25
|
305.89 |
1031.64 |
967.43 |
|
|
| |
3 |
CAPITAL EMPLOYED |
|
|
|
|
|
|
| |
|
(Segment assets - Segment
Liabilities) |
|
|
|
|
|
|
| |
a) |
Research &
Development |
1518.75 |
761.00 |
1518.75
|
761.00 |
|
|
| |
d) |
Net assets which
are not segmented and |
10285.86 |
6720.00 |
10285.86
|
6720.00 |
|
|
| |
|
used commonly |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
TOTAL |
11804.61 |
7481.00 |
11804.61 |
7481.00 |
|
|
| |
Notes: |
1).The
above results were approved and taken on record at the Board of
Directors' meeting held on 26th,Apl 2004 |
|
|
| |
|
2).
Status of invester grievence :- Opening bal : 0, Received :135,Resolved :135,
Closing bal : 0 . |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
For Suven Life Sciences
Ltd |
|
|
|
| |
|
Place : Hyderabad. |
|
|
|
|
|
| |
|
Date : 26.04.2004. |
|
Venkat
Jasti - Managing Director |
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
